Humanitas Research Hospital

Humanitas Research Hospital is a leading Italian hospital and clinical research center located in Rozzano, on the southern outskirts of Milan. Established in 1996 as part of the Humanitas Group, it has rapidly grown to become one of Italy's most important healthcare institutions. The hospital holds JCI (Joint Commission International) accreditation and has been designated as an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), the Italian government's highest recognition for clinical research institutions.

With 734 beds and a medical staff of over 500 physicians, Humanitas Research Hospital is a comprehensive center of excellence. It is particularly renowned for oncology (with one of Italy's most advanced cancer treatment programs), cardiovascular medicine (including complex cardiac surgery and interventional cardiology), orthopedics (specializing in joint replacement and sports medicine), neurosciences, and robotic surgery. The hospital is one of Europe's highest-volume centers for robotic-assisted procedures, utilizing the latest da Vinci surgical systems across multiple specialties.

Humanitas is deeply committed to clinical research, with over 1,500 active research projects and close collaboration with Humanitas University, its affiliated medical school. The hospital's researchers have contributed significantly to advances in immunology, autoimmune diseases, cancer biology, and surgical techniques.

The hospital's modern campus features state-of-the-art technology, including advanced radiation therapy systems, hybrid operating rooms, and comprehensive diagnostic imaging capabilities. Its combination of clinical excellence, research leadership, and international accreditation has made it a destination for patients from across Europe and beyond.

Humanitas Research Hospital provides a comprehensive portfolio of specialist medical and surgical services anchored by its most internationally recognized programs in oncology, cardiovascular medicine, orthopedics, and robotic surgery.

The Cancer Center at Humanitas is one of Italy's most advanced, delivering multidisciplinary oncological care through tumor boards that integrate surgical, medical, and radiation oncology for all solid tumor types. Medical oncology offers precision therapy, immunotherapy (checkpoint inhibitors, targeted therapy), and access to clinical trials. Radiation oncology utilizes advanced IMRT, VMAT, IGRT, and stereotactic body radiotherapy (SBRT) platforms.

The Cardiovascular Center encompasses complex open cardiac surgery (coronary bypass, valve repair and replacement, aortic surgery), interventional cardiology (coronary angioplasty, TAVI, MitraClip, complex electrophysiology and ablation), and cardiac imaging. Orthopedics and traumatology covers primary and revision total knee and hip arthroplasty, arthroscopic surgery, sports medicine and ligament reconstruction, and complex spine surgery — drawing significant volume from sports injury patients.

Humanitas is one of Europe's highest-volume robotic surgery centers, with multiple da Vinci Surgical Systems deployed across urology (prostatectomy, nephrectomy), gynecology (hysterectomy, myomectomy, endometriosis surgery), general surgery (colectomy, hernia, cholecystectomy), and thoracic surgery (lobectomy). Gastroenterology and digestive endoscopy, rheumatology and immunology (Humanitas has particular expertise in autoimmune diseases), ophthalmology, dermatology, pulmonology, and ENT complete the comprehensive offering.

Humanitas Research Hospital operates a modern, purpose-built campus in Rozzano, approximately 10 kilometres south of Milan's city centre, easily accessible by public transport and road from central Milan. The campus hosts 734 inpatient beds across specialized clinical wards for oncology, cardiovascular, orthopedic, and general medical patients.

The surgical complex includes more than 27 operating theatres — among the largest concentrations of OR capacity in northern Italian private hospitals — including dedicated suites for cardiac surgery, multiple robotic surgery suites housing the latest da Vinci Xi Surgical Systems, hybrid operating rooms for combined surgical and fluoroscopic procedures, and orthopedic theatres with laminar flow environments. The 24-hour emergency department manages acute medical and surgical presentations.

Radiation oncology is equipped with linear accelerators delivering IMRT, VMAT, and SBRT. Diagnostic imaging includes 3T MRI, 128-slice CT, PET-CT, digital mammography, breast MRI, and a comprehensive interventional radiology suite. Multiple intensive care units — general ICU, cardiac ICU, and neurological ICU — provide critical care capacity.

The biomedical research infrastructure at Humanitas is among Italy's most productive, with over 1,500 active research projects and close collaboration with Humanitas University. The clinical trials unit manages Phase I–III trials across oncology, cardiology, rheumatology, and surgical innovation. The immunology and autoimmune disease research program is internationally recognized, with publications in leading scientific journals. Research and clinical operations are co-located on the Rozzano campus, enabling rapid translation of scientific findings into clinical practice.

Humanitas Research Hospital has a dedicated International Patient Department that serves patients from around the world. Services include pre-arrival medical evaluation and personalized treatment plans, dedicated multilingual patient coordinators, assistance with travel arrangements and medical visa documentation, airport transfers and transportation to the hospital, accommodation arrangements for patients and accompanying family members, interpreter services during consultations and procedures, international insurance coordination and direct billing agreements, and post-discharge follow-up and remote consultation services. Milan is one of Europe's best-connected cities with two international airports (Malpensa and Linate). Treatment costs at Humanitas are at moderate European levels, generally lower than hospitals in Switzerland, Germany, or the UK for comparable quality of care.

Humanitas is particularly attractive to international oncology and orthopedic patients who seek the combination of IRCCS research status (providing clinical trial access), JCI accreditation (confirming international safety standards), and Milan's cultural appeal. The hospital sees significant volumes of patients from the Middle East, Russia, Eastern Europe, and North Africa in addition to European patients.

Humanitas Research Hospital holds JCI (Joint Commission International) accreditation, the world's most recognized international hospital quality standard, confirming that the hospital meets rigorous global benchmarks across patient safety, clinical care, infection control, medication management, and hospital governance. JCI accreditation is periodically resurveyed and is a key assurance indicator for international patients evaluating European private hospitals.

The hospital holds the IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) designation from the Italian Ministry of Health, confirming its status as a national center of excellence for both clinical care and biomedical research. The IRCCS designation is maintained through ongoing review of research productivity and clinical excellence, and provides access to national research funding and the IRCCS national network. Humanitas's IRCCS designation recognizes its research excellence in oncology, immunology, and cardiovascular medicine.

The hospital operates under the Accreditamento Regionale (Regional Accreditation) framework of the Lombardy Region, confirming compliance with regional standards for all licensed clinical departments and specialties. As a teaching hospital for Humanitas University, it is subject to academic quality assurance applicable to Italian medical education. Humanitas participates in international clinical quality registries and trial networks, enabling ongoing external benchmarking of clinical outcomes.